Acorda Therapeutics Stock News

Read more about India's drug regulator grants Gilead Sciences marketing authorization for remdesivir on Devdiscourse

An earlier study results showed that when treating patients with severe disease - those who require non-invasive supplemental oxygen - 5 days of remdesivir led to similar improvements as a 10-day cour

Read more about Novacyt shares drop as France refuses to refund virus test on Devdiscourse

Read more about India's drug regulator grants Gilead Sciences marketing authorisation for remdesivir on Devdiscourse

Read more about Strides Pharma gets USFDA nod for generic ointment to treat skin conditions on Devdiscourse

India's drug regulator has granted US pharma giant Gilead Sciences marketing authorisation for its anti-viral drug remdesivir for "restricted emergency use" on hospitalised COVID-19 patients.

Sensex advanced 522 points or 1.6% to close at 33,825. Nifty climbed 153 points or 1.6% to end at 9,979.Bajaj Finance, Kotak Bank and IndusInd Bank, surging 6-8% were top Sensex gainers

India's drug regulator has granted US pharma giant Gilead Sciences marketing authorisation for its anti-viral drug remdesivir for 'restricted emergency use' on hospitalised COVID-19 patients in view o

Read more about India's drug regulator grants Gilead Sciences marketing authorization for remdesivir on Devdiscourse

The United States Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for Impella RP to include patients suffering from

It was scorching hot on Saturday afternoon in Lokoja, Kogi, when Godwin (not real name) managed to drag himself to one of the hospitals in th

The company has been granted licence for emergency use of CytoSorb, an extracorporeal blood purification device CytoSorb to reduce pro-inflammatory cytokines levels, to treat COVID-19 patients who are

Aurinia Pharmaceuticals Inc. (Nasdaq:AUPH / TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancin

The